mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.3 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.3 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.3 |
mRNA |
CEP-701 |
GDSC1000 |
pan-cancer |
AAC |
-0.031 |
0.3 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |